Holen Sie sich die Stockscreener-App
35.01
0.82%
-0.3042
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt HROW?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$35.31
Offen:
$35.23
24-Stunden-Volumen:
223.40K
Relative Volume:
0.31
Marktkapitalisierung:
$1.30B
Einnahmen:
$272.30M
Nettoeinkommen (Verlust:
$-5.14M
KGV:
-214.10
EPS:
-0.1635
Netto-Cashflow:
$42.76M
1W Leistung:
+5.17%
1M Leistung:
-3.66%
6M Leistung:
-16.94%
1J Leistung:
+48.89%
1-Tages-Spanne:
$34.92
$35.94
1-Wochen-Bereich:
$34.00
$36.51
52-Wochen-Spanne:
$20.85
$54.85
Harrow Inc Stock (HROW) Company Profile
Firmenname
Harrow Inc
Sektor
Telefon
615.733.4731
Adresse
1A BURTON HILLS BLVD, NASHVILLE, CA
Compare HROW vs TAK, ZTS, HLN, TEVA, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HROW
Harrow Inc
|
35.01 | 1.31B | 272.30M | -5.14M | 42.76M | -0.1635 |
TAK
Takeda Pharmaceutical Co Adr
|
18.22 | 59.20B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
118.20 | 49.79B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.935 | 44.27B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.66 | 35.03B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
555.64 | 24.75B | 3.18B | 1.33B | 1.04B | 27.90 |
Harrow Inc Stock (HROW) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-11 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-06-12 | Eingeleitet | BTIG Research | Buy |
| 2025-06-10 | Eingeleitet | William Blair | Outperform |
| 2025-02-06 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-12-04 | Bestätigt | B. Riley Securities | Buy |
| 2024-04-11 | Eingeleitet | Craig Hallum | Buy |
| 2022-09-08 | Fortgesetzt | B. Riley Securities | Buy |
| 2021-10-14 | Fortgesetzt | B. Riley Securities | Buy |
| 2021-09-24 | Eingeleitet | Aegis Capital | Buy |
| 2021-07-02 | Eingeleitet | Ladenburg Thalmann | Buy |
Alle ansehen
Harrow Inc Aktie (HROW) Neueste Nachrichten
HROW Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
HROW Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Harrow announces $50M add-on senior notes offering - MSN
Harrow outlines $350M–$365M 2026 revenue goal as sales force expansion and pipeline advances fuel momentum - MSN
HROW News | HARROW INC (NASDAQ:HROW) - ChartMill
Institution Moves: Is Harrow Inc attractive for institutional investors2026 Short Interest & AI Forecasted Entry/Exit Points - baoquankhu1.vn
BTIG Maintains Buy on Harrow Health, Inc. (HROW) March 2026 - Meyka
A Major Investor Just Sold $7.8 Million in Harrow Stock -- Is This a Sell Signal? - AOL.com
HROW6348836 Bond Coupon Analysis — Rate & Payments - TradingView
HROW6348836 Bond Risk Analysis - TradingView
HROW Stock Price, Quote & Chart | HARROW INC (NASDAQ:HROW) - ChartMill
Harrow prices $50M senior unsecured notes due 2030 at 8.625% - MSN
Layoff Watch: Will Harrow Inc stock recover after earnings2026 Retail Activity & Low Drawdown Momentum Ideas - baoquankhu1.vn
Will Harrow Inc benefit from geopolitical trends2026 Fundamental Recap & Reliable Entry Point Trade Alerts - baoquankhu1.vn
Discipline and Rules-Based Execution in HROW Response - Stock Traders Daily
What Harrow (HROW)'s New US$50 Million Senior Notes Offering Means For Shareholders - Yahoo Finance
Harrow Health Expands Senior Notes Offering for Growth - TipRanks
Harrow Raises $50 Million Via Additional 8.625% Senior Notes Due 2030; Signs Purchase Agreement and Indenture - TradingView
Harrow (NASDAQ: HROW) sells $50M of 8.625% notes due 2030 - Stock Titan
Vanguard disaggregates holdings — Harrow Inc (HROW) reports 0 shares - Stock Titan
Opaleye Trims Harrow Stake After Earnings Miss While Debt Risk Rises - Sahm
Craig-Hallum Keeps Their Buy Rating on Harrow Health (HROW) - The Globe and Mail
Is Harrow Inc currently under institutional pressure2026 Trading Volume Trends & AI Driven Price Forecasts - baoquankhu1.vn
HARROW INC (NASDAQ:HROW): A GARP Stock with Strong Growth at a Reasonable Price - ChartMill
HROW6348836 Bond Price and Chart — FINRA:HROW6348836 - TradingView
Harrow Announces Add-On Offering of $50.0 Million of Senior Unsecured Notes to Support Growth - Bitget
Harrow Announces $50 Million Senior Unsecured Notes Offering Due 2030 to Accelerate Growth and Product Development 12 - Minichart
Harrow Health Prices $50 Million Senior Notes Offering - TipRanks
How Investors May Respond To Harrow (HROW) Issuing US$50M In 8.625% Senior Notes For Growth - simplywall.st
Harrow Announces Pricing of $50.0 Million Offering of Senior Unsecured Notes Due 2030 - The Manila Times
Harrow (NASDAQ: HROW) adds $50M to 8.625% 2030 senior notes - Stock Titan
Harrow Health Announces $50 Million Senior Notes Offering - TipRanks
Harrow Announces $50 Million Add-On Offering of 8.625% Senior Unsecured Notes Due 2030 to Support Growth - Minichart
A Major Investor Just Sold $7.8 Million in Harrow Stock -- Is This a Sell Signal? - The Motley Fool
Harrow to Issue Additional $50 Million Debt Offering - marketscreener.com
Harrow launches $50.0M add-on 8.625% senior notes due 2030 for growth initiatives - TradingView
Harrow (NASDAQ: HROW) plans $50M add-on 8.625% 2030 note issue - stocktitan.net
HC Wainwright Issues Positive Outlook for Harrow Earnings - MarketBeat
Finanzdaten der Harrow Inc-Aktie (HROW)
Umsatz
Nettogewinn
Free Cashflow
ENV
Harrow Inc-Aktie (HROW) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Opaleye Management Inc. | 10% Owner |
Mar 03 '26 |
Sale |
39.15 |
60,309 |
2,361,242 |
63,691 |
| Opaleye Management Inc. | 10% Owner |
Feb 27 '26 |
Sale |
54.18 |
5,000 |
270,900 |
65,000 |
| Opaleye Management Inc. | 10% Owner |
Jan 06 '26 |
Sale |
53.35 |
20,000 |
1,066,914 |
70,000 |
| BOLL ANDREW R. | PRESIDENT AND CFO |
Dec 12 '25 |
Option Exercise |
3.95 |
60,000 |
237,000 |
837,844 |
| BAUM MARK L | CHIEF EXECUTIVE OFFICER |
Dec 12 '25 |
Option Exercise |
3.95 |
180,000 |
711,000 |
3,066,124 |
| BAUM MARK L | CHIEF EXECUTIVE OFFICER |
Jul 21 '25 |
Option Exercise |
7.87 |
600,000 |
4,722,000 |
3,199,462 |
| Opaleye Management Inc. | 10% Owner |
Jun 10 '25 |
Sale |
30.80 |
15,000 |
462,033 |
90,000 |
| Opaleye Management Inc. | 10% Owner |
Jun 09 '25 |
Sale |
30.37 |
15,204 |
461,794 |
105,000 |
| Opaleye Management Inc. | 10% Owner |
Jun 03 '25 |
Sale |
30.04 |
3,000 |
90,116 |
122,000 |
| Opaleye Management Inc. | 10% Owner |
Jun 04 '25 |
Sale |
30.02 |
1,796 |
53,907 |
120,204 |
1.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):